Nephrogenic Systemic Fibrosis Clinical Trials

Clinical Trial: Nephrogenic Systemic Fibrosis (NSF): A Chart Review With Analysis of Tissue Gadolinium Levels

Post-Marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-Enhanced Magnetic Resonance Imaging (MRI)

Primovist / Eovist in Renally Impaired Patients

Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease

Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease

Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)

Safety of Gadovist in Renally Impaired Patients

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection (SHERLOC)

Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis (GENESYF)

Renal & Urology News
E-Newsletters

Sign up today to start receiving one of three free e-newsletters from Renal & Urology News or get them all.
- eTOC (print edition preview)
- RUN Roundup
- Conference Highlights

Sample | Subscribe | Archive


Your Money

Visit Your Money for the latest financial news and advice.

myCME Spotlight

mycme.com is an online source of dozens of free CME courses for nephrologists, urologists and other health-care professionals including OAB in Women....and in Men: Recognizing and Managing Different Symptom Complexes.

 Subscribe to the RSS for this page  [view all our RSS feeds here]
Popular Topics
Acute Kidney Injury Adrenal Gland Bladder Cancer BPH Brachytherapy Cardiovascular Disease Chronic Kidney Disease CKD Diabetes Diabetes Mellitus Dialysis End-stage Renal Disease Epidemiology FSGS Hemodialysis Hypertension Hypogonadism Incontinence Kidney Cancer Kidney Disease Obesity Prostate Cancer Renal Cell Carcinoma Reproductive Medicine Transplantation